Bottom line
What is DRNJX's expense ratio?
DRNJX's expense ratio is 0.84%, or about $84 a year on every $10,000 invested. That is more expensive than 73% of municipal bond funds we track (median 0.63%). This share class also charges a front-end sales load of up to 4.5%, taken from your investment when you buy.
Updated Apr 28, 2026
DRNJX fee table
| Net expense ratio | 0.84% |
|---|---|
| Gross expense ratio | 0.84% |
| Management fee | 0.45% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.39% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 4.5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Apr 28, 2026
What DRNJX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DRNJX | $532 | $706 | $895 | $1,440 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.84% expense ratio costs roughly $47,200 in lost growth, versus about $36,000 for the median municipal bond fund (0.63%).